Omid Vakili

6.0k total citations · 2 hit papers
48 papers, 1.3k citations indexed

About

Omid Vakili is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Omid Vakili has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 20 papers in Cancer Research and 11 papers in Epidemiology. Recurrent topics in Omid Vakili's work include MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (13 papers) and Circular RNAs in diseases (11 papers). Omid Vakili is often cited by papers focused on MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (13 papers) and Circular RNAs in diseases (11 papers). Omid Vakili collaborates with scholars based in Iran, United States and United Kingdom. Omid Vakili's co-authors include Mortaza Taheri‐Anganeh, Amir Savardashtaki, Ahmad Movahedpour, Seyyed Hossein Khatami, Marzieh Asadi, Saeed Taghizadeh, Elina Kaviani, Mahshid Tahamtan, Hassan Ghasemi and Alireza Mafi and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and European Journal of Pharmacology.

In The Last Decade

Omid Vakili

47 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Caspase‐3: Structure, function, and biotechnological aspects

2021 325 citations Omid Vakili et al. profile →
Laccase: Various types and applications

2022 120 citations Seyyed Hossein Khatami, Omid Vakili et al. profile →

Peers

Countries citing papers authored by Omid Vakili

Since Specialization

Citations

This map shows the geographic impact of Omid Vakili's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omid Vakili with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omid Vakili more than expected).

Fields of papers citing papers by Omid Vakili

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omid Vakili. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omid Vakili. The network helps show where Omid Vakili may publish in the future.

Co-authorship network of co-authors of Omid Vakili

This figure shows the co-authorship network connecting the top 25 collaborators of Omid Vakili. A scholar is included among the top collaborators of Omid Vakili based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omid Vakili. Omid Vakili is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Digital footprints of play: Decoding child-friendliness of cities through PPGIS 2025 ·Cities ·(unknown), Claire Freeman, Christina R. Ergler, Frans Sijtsma, Omid Vakili, (unknown)	0
2	Signaling pathways and molecular mechanisms involved in the onset and progression of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL); a focus on Notch3 signaling 2025 ·The Journal of Headache and Pain ·(unknown), (unknown), Omid Vakili	3
3	Autophagy and the peroxisome proliferator-activated receptor signaling pathway: A molecular ballet in lipid metabolism and homeostasis 2025 ·Molecular and Cellular Biochemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sayed Mohammad Shafiee, (unknown), (unknown), Seyyed Hossein Khatami, Saeed Karima, Omid Vakili, Morteza Pourfarzam	6
4	Metabolic biomarkers in irritable bowel syndrome diagnosis 2024 ·Clinica Chimica Acta ·Omid Vakili, Peyman Adibi, Morteza Pourfarzam	3
5	Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms 2024 ·Cell Communication and Signaling ·(unknown), (unknown), (unknown), (unknown), (unknown), Mina Alimohammadi, (unknown), (unknown), (unknown), Alireza Mafi, Omid Vakili	19
6	From fun to function: PPGIS unlocks the power of play in cities 2024 ·Applied Geography ·(unknown), Frans Sijtsma, Claire Freeman, Christina R. Ergler, (unknown), (unknown), (unknown), Omid Vakili	3
7	Protective and curative effects of unconjugated bilirubin on gene expression of LOX-1 and iNOS in the heart of rats receiving high-fat diet and low dose streptozotocin: a histomorphometric approach 2024 ·Journal of Inflammation ·(unknown), Omid Vakili, (unknown), (unknown), (unknown), (unknown), Amirreza Dehghanian, Lobat Tayebi, Sayed Mohammad Shafiee	6
8	Bilirubin, a hepatoprotective agent that activates SIRT1, PGC-1α, and PPAR-α, while inhibiting NF-κB in rats with metabolic-associated fatty liver disease 2024 ·Scientific Reports ·(unknown), (unknown), Omid Vakili, (unknown), (unknown), Amirreza Dehghanian, (unknown), Sayed Mohammad Shafiee	4
9	Electrochemical biosensors for early diagnosis of glioblastoma 2024 ·Clinica Chimica Acta ·(unknown), (unknown), (unknown), (unknown), (unknown), Ahmad Movahedpour, Omid Vakili, Seyyed Hossein Khatami	18
10	Nutritional Strategies in Major Depression Disorder: From Ketogenic Diet to Modulation of the Microbiota-Gut-Brain Axis 2024 ·Molecular Neurobiology ·(unknown), (unknown), (unknown), Ehsan Dadgostar, (unknown), (unknown), (unknown), Omid Vakili, Seyyed Hossein Khatami	3
11	The crosstalk between ubiquitin-conjugating enzyme E2Q1 and p53 in colorectal cancer: An in vitro analysis 2023 ·Medical Oncology ·(unknown), (unknown), Omid Vakili, Sanaz Dastghaib, Atefeh Seghatoleslam, Sayed Mohammad Shafiee	1
12	Bilirubin improves renal function by reversing the endoplasmic reticulum stress and inflammation in the kidneys of type 2 diabetic rats fed high-fat diet 2023 ·Chemico-Biological Interactions ·(unknown), (unknown), Omid Vakili, (unknown), (unknown), Amirreza Dehghanian, (unknown), Sayed Mohammad Shafiee	15
13	Ameliorative effects of bilirubin on cell culture model of non-alcoholic fatty liver disease 2023 ·Molecular Biology Reports ·Omid Vakili, (unknown), (unknown), Sayed Mohammad Shafiee	14
14	Bilirubin, an endogenous antioxidant that affects p53 protein and its downstream apoptosis/autophagy-related genes in LS180 and SW480 cell culture models of colorectal cancer 2023 ·Biochemical and Biophysical Research Communications ·(unknown), (unknown), (unknown), (unknown), Omid Vakili, Sayed Mohammad Shafiee	7
15	The Effects of Statins on Respiratory Symptoms and Pulmonary Fibrosis in COVID-19 Patients with Diabetes Mellitus: A Longitudinal Multicenter Study 2023 ·Archivum Immunologiae et Therapiae Experimentalis ·(unknown), (unknown), Tania Dehesh, Nima Taefehshokr, (unknown), Katarzyna Kotfis, (unknown), Amir Ravandi, (unknown), Omid Vakili, Beniamin Oskar Grabarek, (unknown), Marek Łoś, Pooneh Mokarram, Saeid Ghavami	5
16	The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms 2023 ·Frontiers in Pharmacology ·Malihe Rezaee, (unknown), (unknown), (unknown), Omid Vakili, (unknown), (unknown), (unknown), (unknown), Seyedeh Sara Ghorbanhosseini, (unknown), Mina Alimohammadi, (unknown), (unknown), Zatollah Asemi, Azadeh Aminianfar, Hamed Mirzaei, Alireza Mafi	33
17	Possible Mechanisms and Molecular Signaling of Incretins against the Development of Type 2 Diabetes Mellitus 2022 ·Current Molecular Pharmacology ·Zatollah Asemi, (unknown), Marziyeh Salami, Alireza Mafi, Mohammad Hossein Aarabi, Omid Vakili	3
18	Novel insights into the role of circular RNAs in Parkinson disease: An emerging renaissance in the management of neurodegenerative diseases 2022 ·Journal of Neuroscience Research ·(unknown), (unknown), (unknown), Fariborz Khorvash, Omid Vakili	22
19	Circular RNAs in Alzheimer’s Disease: A New Perspective of Diagnosticand Therapeutic Targets 2022 ·CNS & Neurological Disorders - Drug Targets ·Omid Vakili, (unknown), Zeinab Babaei, (unknown), (unknown), Zatollah Asemi, Alireza Mafi	25
20	Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy 2021 ·Pathology - Research and Practice ·Alireza Mafi, (unknown), Marziyeh Salami, (unknown), Omid Vakili, Esmat Aghadavod	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact